info@synchemia.com | sales@synchemia.com 
9766925136 | 72 
N-Nitroso Oxcarbazepine EP Impurity H
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Oxcarbazepine is also sometimes used to treat bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of frenzied abnormal excitement, and other abnormal moods).N-Nitroso Oxcarbazepine EP Impurity H is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Oxcarbazepine EP Impurity H CAS NO:NA Chemically represented as10-Methoxy-5-nitroso-5H-dibenzo[b,f]azepine.Synchemia is the leading manufacturing and exporter of N-Nitroso Oxcarbazepine EP Impurity H.We supply N-Nitroso Oxcarbazepine EP Impurity H with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N014484 |
| CAS No | NA |
| Mol.F. | C40H48N10O8 |
| Mol.Wt. | 796.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014485 |
| CAS No | NA |
| Mol.F. | C40H49N9O7 |
| Mol.Wt. | 767.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014486 |
| CAS No | NA |
| Mol.F. | C24H24ClFN6O3 |
| Mol.Wt. | 498.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014487 |
| CAS No | NA |
| Mol.F. | C14H20N4O3S |
| Mol.Wt. | 324.4 g/mol |
| INV STATUS | In Stock |
.png)
| CAT No | SRC-N014488 |
| CAS No | NA |
| Mol.F. | C16H14ClFN4O |
| Mol.Wt. | 332.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014489 |
| CAS No | 96806-34-7 |
| Mol.F. | C5H10ClN3O3 |
| Mol.Wt. | 195.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014490 |
| CAS No | NA |
| Mol.F. | C12H13N3O |
| Mol.Wt. | 215.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014491 |
| CAS No | NA |
| Mol.F. | C16H13F3N4O3S |
| Mol.Wt. | 398.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014492 |
| CAS No | NA |
| Mol.F. | C19H19N3O4 |
| Mol.Wt. | 353.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014493 |
| CAS No | NA |
| Mol.F. | C22H25N3O3S |
| Mol.Wt. | 411.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014494 |
| CAS No | NA |
| Mol.F. | C19H16F6N8O2 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014495 |
| CAS No | NA |
| Mol.F. | C19H15F6N9O3 |
| Mol.Wt. | 531.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014496 |
| CAS No | NA |
| Mol.F. | C19H16F6N8O2 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014497 |
| CAS No | NA |
| Mol.F. | C22H26ClFN8O5S |
| Mol.Wt. | 569.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014498 |
| CAS No | NA |
| Mol.F. | C25H29N7O3 |
| Mol.Wt. | 475.6 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014500 |
| CAS No | NA |
| Mol.F. | C16H24N2O5 |
| Mol.Wt. | 324.4 g/mol |
| INV STATUS | In Stock |
